Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Oncology
M&A
Pharmaceutical
Licensing
DNA repair
Partnering
DNA Damage Response
Translational research
Epigenetics
Biopharma
HDAC
Cancer
Date founded
2014
Funding rounds raised
Total raised
$8.7M
from 2 investors over 2 rounds
O
Onxeo S.A. raised $8.7M on April 6, 2022
Investors: The Invus Group
O
Onxeo S.A. raised $6.3M on June 15, 2018
Investors: Nice & Green SA, Proprietary Equity Investment & Alternative Financing